Conference Reports

By Lorraine L. Janeczko

NASHVILLE, Tenn -- September 21, 2018 -- Patisiran lowers N-terminal-pro-brain natriuretic peptide (NT-proBNP) in patients with hereditary transthyretin-mediated (hATTR) amyloidosis, regardless of whether the patient is being treated with diuretics, according to a...

By Walter Alexander

MUNICH, Germany -- August 30, 2018 -- Treatment with febuxostat in patients aged ≥65 years with hyperuricemia (gout) significantly reduces serum uric acid level and its effects compared with conventional therapy (allopurinol) and lifestyle modification, according to...

By Shazia Qureshi

AMSTERDAM, the Netherlands -- June 19, 2018 -- In patients with axial spondyloarthropathy (axSpA), lateral dual-energy x-ray absorptiometry (DXA) of the spine may be more accurate for assessing spinal bone mineral density (BMD) compared with the traditional antero-...

By Shazia Qureshi

AMSTERDAM, the Netherlands -- June 19, 2018 -- In an observational cohort of patients with juvenile idiopathic arthritis (JIA), the risk of developing new-onset uveitis did not appear to be higher with etanercept compared with methotrexate, even after taking age and...

By Shazia Qureshi

AMSTERDAM, the Netherlands -- June 18, 2018 -- In patients undergoing ultrasound-guided percutaneous lavage (UGPL) as a treatment for rotator cuff calcific tendinopathy, a single injection of methylprednisolone in the subacromial bursa (SAB) reduced pain in the week...

By Shazia Qureshi

AMSTERDAM, the Netherlands -- June 18, 2018 -- In an observational study of 248 patients with systemic sclerosis receiving treatment with rituximab, skin, lung, and joint involvement appeared to improve over the 2.4 years of follow-up, researchers reported here at the...

By Shazia Qureshi

AMSTERDAM, the Netherlands -- June 18, 2018 -- In patients with gout who received urate-lowering therapy in a tight-control, treat-to-target design, ultrasound was able to visualise the reduction of the uric acid load over the course of 12 months of treatment, according...

By Shazia Qureshi

AMSTERDAM, the Netherlands -- June 15, 2018 -- Compared with placebo, upadacitinib was effective in patients with active rheumatoid arthritis who had an inadequate response to conventional synthetic disease-modifying antirheumatic drugs (DMARDs), researchers reported...

By Brian Hoyle

CHICAGO -- June 5, 2018 -- In women with breast cancer and obesity, a once-daily oral therapy of omega 3-fatty acid can reduce arthralgia that may arise during aromatase-inhibitor (AI) therapy, according to findings from a post-hoc analysis of the SWOG S0927 trial,...

Pages